We are live on ! Find out more
State Street

State Street Portfolio holdings

AUM $2.9T
1-Year Est. Return 29.55%
 

State Street Corporation, established in 1792 and headquartered in Boston, Massachusetts, is one of the oldest financial institutions in the United States and a major player in the global asset management and custody banking sectors. Primarily known for its custodial services, it safeguards assets for institutional investors, managing trillions of dollars through its State Street Global Advisors (SSGA) division, which is renowned for launching the first U.S. exchange-traded fund (ETF), the SPDR S&P 500 ETF (SPY), in 1993. The company provides a range of services including investment management, research, trading, and data analytics, catering mostly to institutional clients like pension funds, endowments, and mutual funds. With a focus on financial infrastructure and innovation, State Street has positioned itself as a key backbone in the global investment ecosystem.

This Fund
S&P 500
This Quarter Est. Return
+9.39%
1 Year Est. Return
+29.55%
3 Year Est. Return
+97.16%
5 Year Est. Return
+133.33%
10 Year Est. Return
+488.13%
AUM
$1.46T
AUM Growth
+$118B
Cap. Flow
+$5.56B
Cap. Flow %
0.38%
Top 10 Hldgs %
17.96%
Holding
3,899
New
94
Increased
2,389
Reduced
1,210
Closed
92

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.79B
2
TFC icon
Truist Financial
TFC
+$1.36B
3
BABA icon
Alibaba
BABA
+$1.05B
4
NOW icon
ServiceNow
NOW
+$945M
5
LVS icon
Las Vegas Sands
LVS
+$421M

Sector Composition

Rank Sector Weight
1 Technology 17.83%
2 Financials 15.11%
3 Healthcare 13.45%
4 Industrials 10.88%
5 Consumer Discretionary 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOK icon
3626
Nokia
NOK
$49.6B
$38K ﹤0.01%
10,205
-594,913
-98% -$2.34M
GSUM
3627
DELISTED
Gridsum Holding Inc.
GSUM
$38K ﹤0.01%
31,049
+5,449
+21% +$10.3K
NEOS
3628
DELISTED
Neos Therapeutics, Inc
NEOS
$37K ﹤0.01%
24,425
-14,961
-38% -$22.4K
DSX icon
3629
Diana Shipping
DSX
$270M
$36K ﹤0.01%
16,522
-23,540
-59% -$57K
MACK
3630
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$35K ﹤0.01%
11,185
DWSN icon
3631
Dawson Geophysical
DWSN
$132M
$34K ﹤0.01%
14,036
SOL
3632
DELISTED
Emeren Group
SOL
$34K ﹤0.01%
24,141
+4,280
+22% +$6.36K
UONEK icon
3633
Urban One Class D
UONEK
$23.1M
$33K ﹤0.01%
1,737
ABUS icon
3634
Arbutus Biopharma
ABUS
$871M
$32K ﹤0.01%
11,686
LINC icon
3635
Lincoln Educational Services
LINC
$1.32B
$31K ﹤0.01%
11,584
LONE
3636
DELISTED
Lonestar Resources US Inc. Class A Common Stock
LONE
$30K ﹤0.01%
11,500
HDSN
3637
Hudson Technologies
HDSN
$263M
$29K ﹤0.01%
29,255
CTIC
3638
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$29K ﹤0.01%
18,052
DXLG icon
3639
Destination XL Group
DXLG
$34.3M
$28K ﹤0.01%
22,082
LRMR icon
3640
Larimar Therapeutics
LRMR
$394M
$28K ﹤0.01%
2,092
-2,423
-54% -$23.1K
DMK
3641
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$27K ﹤0.01%
550
AMPE
3642
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$27K ﹤0.01%
156
KA
3643
DELISTED
Kineta, Inc. Common Stock
KA
$26K ﹤0.01%
80
BLCM
3644
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$25K ﹤0.01%
1,910
-3,644
-66% -$33.6K
MVIS icon
3645
Microvision
MVIS
$86.2M
$23K ﹤0.01%
32,402
VIVS
3646
VivoSim Labs
VIVS
$1.33M
$23K ﹤0.01%
266
LBY
3647
DELISTED
Libbey, Inc.
LBY
$23K ﹤0.01%
15,548
CRIS icon
3648
Curis
CRIS
$9.39M
$21K ﹤0.01%
31
TRVN
3649
DELISTED
Trevena, Inc.
TRVN
$21K ﹤0.01%
39
-139
-78% -$71.3K
ALTO icon
3650
Alto Ingredients
ALTO
$342M
$19K ﹤0.01%
29,552

Similar funds

State Street's Q4 2019 Portfolio in Review

As of Q4 2019, State Street held 3,899 positions worth $1.46T, up 8.8% from $1.34T the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 4.8%. State Street opened 94 new positions and exited 92, leaving the 3,899-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • State Street's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 98,000 shares worth $114M.
  • State Street added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.79B increase.
  • State Street's biggest Q4 2019 reduction was Cummins, cutting an estimated $607M.
  • State Street fully exited Celgene Corp in Q4 2019, selling an estimated $2.96B.
  • State Street's ten largest holdings make up 18% of its $1.46T portfolio in Q4 2019.
  • State Street opened 94 new positions and closed 92 in Q4 2019.
  • State Street's portfolio value rose 8.8% quarter-over-quarter to $1.46T.

Based on State Street's 13F filing for Q4 2019, filed 6 Feb 2020.